Skip to main content
. 2021 Dec 8;11:623. doi: 10.1038/s41398-021-01737-5

Fig. 2. Drug-discovery results for CUD using human brain data.

Fig. 2

Panel (A) shows repurposable compounds negatively associated with CUD gene expression in the brain (all padj < 0.05). Panel (B) shows the results of the medications currently undergoing clinical trials for CUD. The x-axis represents the weighted average of a compound’s correlation coefficients with the human brain CUD genes and each compound’s weighted standard error bars. Also, note that the black circles represent the effect across all brain regions/studies and the points below are color coded by brain region.